Safety and Efficacy of γδ T Cell Against Gastric Cancer

NCT02585908 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

BIOLOGICAL: CIK
BIOLOGICAL: γδ T
BIOLOGICAL: CIK and γδ T

Sponsor

Beijing Doing Biomedical Co., Ltd.